DEFA14A ·Filed Apr 22, 2026
Proxy solicitation materials
Actionable Insight • Neutral
No immediate trading implications from this routine proxy filing. Monitor next quarterly earnings for any updates on business performance.
Final — all horizons settled through T+60d
PMVP ▼ -9.46% at T+60d
NEUTRAL call -9.46% · α vs SPY -14.24% · entry $1.48 → $1.34
T+1d
-3.38%
call -3.38% · α -2.98%
$1.43
settled 6mo ago
T+5d
-5.07%
call -5.07% · α -5.12%
$1.41
settled 6mo ago
T+20d
-11.49%
call -11.49% · α -14.65%
$1.31
settled 5mo ago
T+60d
-9.46%
call -9.46% · α -14.24%
$1.34
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
PMV Pharmaceuticals is holding its annual shareholder meeting to elect directors and approve executive compensation. The filing is a routine proxy statement with no material financial or strategic developments.
Key Financial Metrics
Vote
director election
Key Facts
- Filing is a DEFA14A proxy statement for annual shareholder meeting
- Purpose is to elect directors and approve executive compensation
- No material financial information or strategic developments disclosed
- Routine corporate governance filing with no surprises
Financial Impact
No material financial impact
revenueepsdebtdilution
Risk Factors
- Low impact as this is a routine governance filing
- No material information disclosed that would affect investment thesis
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-016039 |
| Document: 0001140361-26-016039-index-headers.html | 0001140361-26-016039 |
| Document: 0001140361-26-016039-index.html | 0001140361-26-016039 |
| Document: 0001140361-26-016039.txt | 0001140361-26-016039 |
11 reports for PMVP
50% Hit rate @ T+20 Went positive at some point 5 of 7 best @ T+20▲ +29.46%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 22d ago | 8-K | $1.78 | awaiting T+20 | — | $1.25 (−29.78%) |
Aug 31, 2026 8w ago | Press Release | $1.29 $1.67 | ▼ −29.46% | ▼ −29.14% | $1.25 (+3.10%) |
Aug 31, 2026 8w ago | 8-K | $1.29 $1.67 | ▲ +29.46% | ▲ +29.14% | $1.25 (−3.10%) |
Aug 31, 2026 8w ago | Press Release | $1.29 $1.67 | ▼ −29.46% | ▼ −29.14% | $1.25 (+3.10%) |
Aug 31, 2026 8w ago | Press Release | $1.29 $1.67 | ▲ +29.46% | ▲ +29.14% | $1.25 (−3.10%) |
Aug 14, 2026 10w ago | 8-K | $1.26 $1.46 | ▲ +15.87% | ▲ +17.86% | $1.25 (−0.79%) |
Aug 14, 2026 10w ago | Press Release | $1.26 $1.46 | ▲ +15.87% | ▲ +17.86% | $1.25 (−0.79%) |
May 12, 2026 24w ago | 8-K | $1.42 $1.06 | ▼ −25.35% | ▼ −23.62% | $1.25 (−11.97%) |
May 12, 2026 24w ago | Press Release | $1.42 $1.06 | ▼ −25.35% | ▼ −23.62% | $1.25 (−11.97%) |
Apr 22, 2026 26w ago | DEFA14A | $1.48 $1.31 | ▼ −11.49% | ▼ −14.65% | $1.25 (−15.54%) |
Showing 10 of 11
US Market Status
Market Closed — Opens Wed (17h 21m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers